Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease

被引:37
作者
Koksch, M
Zeiger, F
Wittig, K
Siegemund, A
Reininger, CB
Pfeiffer, D
Ruehlmann, C
机构
[1] Univ Leipzig, Abt Kardiol & Angiol, Med Klin & Poliklin 1, Leipzig, Germany
[2] Univ Leipzig, Inst Klin Chem, Leipzig, Germany
[3] Univ Munich, Chirurg Klin & Poliklin, Klinikum Innenstadt, Munich, Germany
关键词
peripheral vascular disease; platelets; coagulation; P-selectin; flow cytometry;
D O I
10.1053/ejvs.2000.1294
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives: to examine coagulation, fibrinolysis, and platelet activity in patients with peripheral vascular disease (PVD). Design: fifty consecutive PVD patients and 50 healthy volunteers. (Prospective comparative study). Materials and methods: P-selectin expression in non-fixed, whole blood was measured flow cytometrically on non-stimulated and ADP- and TRAP-6-stimulated samples. Plasma fibrinogen, von Willebrand factor (vWF), tissue plasminogen activator (tPA), and plasminogen activator inhibitor-1 were determined using standard techniques. Disease severity was stratified on the basis of the ankle-brachial pressure index (ABPI) and the angiographic data were assessed using the Bollinger score. Results: coagulation and fibrinolysis parameters as well as the P-selectin expression on both standard and non-stimulated platelets were significantly increased in patients vs controls (all P<0.01). The respective sensitivity and specificity were as follows: P-selectin expression (81%, 94%), vWF (72%, 86%), fibrinogen (64%, 98%), PAI-1 (44%, 90%, tPA (15%, 100%). P-selectin expression on TRAP-6-stimulated MP correlated with disease severity (r = 0.40, p < 0.01). Conclusions: these findings support the concept of ongoing thrombogenesis in the subclinical progression of PVD and demonstrate the high diagnostic sensitivity of flow cytometric analysis of platelet activation.
引用
收藏
页码:147 / 154
页数:8
相关论文
共 39 条
  • [1] ALZAHRANI H, 1992, CLIN HEMORHEOL, V12, P867
  • [2] BADIMON L, 1993, THROMB HAEMOSTASIS, V70, P111
  • [3] THE CLINICAL USE OF FLOW-CYTOMETRY FOR ASSESSING PLATELET ACTIVATION IN ACUTE CORONARY SYNDROMES
    BECKER, RC
    TRACY, RP
    BOVILL, EG
    MANN, KG
    AULT, K
    [J]. CORONARY ARTERY DISEASE, 1994, 5 (04) : 339 - 345
  • [4] SEMI-QUANTITATIVE ASSESSMENT OF LOWER-LIMB ATHEROSCLEROSIS FROM ROUTINE ANGIOGRAPHIC IMAGES
    BOLLINGER, A
    BREDDIN, K
    HESS, H
    HEYSTRATEN, FMJ
    KOLLATH, J
    KONTTILA, A
    POULIADIS, G
    MARSHALL, M
    MEY, T
    MIETASCHK, A
    ROTH, FJ
    SCHOOP, W
    [J]. ATHEROSCLEROSIS, 1981, 38 (3-4) : 339 - 346
  • [5] CHANG CP, 1993, J BIOL CHEM, V268, P7171
  • [6] Chesebro JH, 1997, HAEMOSTASIS, V27, P12
  • [7] Platelet glycoprotein IIb/IIIa receptor blockade in unstable coronary disease
    Chesebro, JH
    Badimon, JJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (21) : 1539 - 1541
  • [8] INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY
    CORTELLARO, M
    COFRANCESCO, E
    BOSCHETTI, C
    MUSSONI, L
    DONATI, MB
    CARDILLO, M
    CATALANO, M
    GABRIELLI, L
    LOMBARDI, B
    SPECCHIA, G
    TAVAZZI, L
    TREMOLI, E
    POZZOLI, E
    TURRI, M
    CORTELLARO, M
    COFRANCESCO, E
    BOSCHETTI, C
    CARDILLO, M
    TORRI, M
    RAINISIO, M
    GENTILE, G
    MOREO, G
    BIANCHI, O
    LEONARDI, P
    COLOMBI, M
    CATALANO, M
    GALIMBERTI, P
    RUSSO, U
    CRESSOTTI, A
    CARZANIGA, G
    NOBILI, S
    NINNO, D
    DONATI, MB
    IACOVIELLO, L
    DEGAETANO, G
    GABRIELLI, L
    MARTELLI, E
    CORSI, G
    LORENZI, G
    LOMBARDI, B
    CARRIERO, MR
    COLOMBO, R
    SPECCHIA, G
    CIOFFI, P
    SCIRE, A
    TAVAZZI, L
    GIANNUZZI, P
    CORRA, U
    TEMPORELLI, L
    MORA, F
    [J]. ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10): : 1412 - 1417
  • [9] CORTELLARO M, 1994, THROMB HAEMOSTASIS, V72, P292
  • [10] Criqui M H, 1997, Vasc Med, V2, P221